Cancer and Coronary Artery Disease: Common Associations, Diagnosis and Management Challenges

被引:0
|
作者
Debashish Das
Alex Asher
Arjun K. Ghosh
机构
[1] St Bartholomew’s Hospital,Cardio
[2] Royal London Hospital,Oncology Service, Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust
[3] University College London Hospital,Department of Cardiology, Barts NHS Health Trust
来源
Current Treatment Options in Oncology | 2019年 / 20卷
关键词
Cancer; Coronary artery disease; Interventional cardio-oncology;
D O I
暂无
中图分类号
学科分类号
摘要
Coronary artery disease (CAD) and cancer often occur in the same patients via common biological pathways and shared risk factors. A variety of chemotherapeutic agents and radiotherapy can influence the development and progression of CAD. The diagnosis of ischaemic heart disease may be challenging in certain cases such as premature CAD secondary to radiotherapy. The management of CAD in cancer patients in the stable, acute and chronic settings can often be complicated by issues related to ongoing or previous cancer treatment or the cancer itself. A multidisciplinary approach in the setting of a cardio-oncology service is often best-served to optimally treat such patients.
引用
收藏
相关论文
共 50 条
  • [21] Diagnosis and management of coronary artery disease in patients with end-stage renal disease on hemodialysis
    deLemos, JA
    Hillis, LD
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (10): : 2044 - 2054
  • [22] Associations between Vaspin Levels and Coronary Artery Disease
    Askin, Lutfu
    Tanriverdi, Okan
    Tibilli, Hakan
    Turkmen, Serdar
    CARDIOVASCULAR INNOVATIONS AND APPLICATIONS, 2020, 4 (03) : 211 - 216
  • [23] Clinical challenges in the management of cardiac amyloidosis complicating aortic stenosis and coronary artery disease
    Raval, Maharshi
    Siddiq, Sajid
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [24] β-Blockers in coronary artery disease management
    Boudonas, G. E.
    HIPPOKRATIA, 2010, 14 (04) : 231 - 235
  • [25] Ranolazine for the management of coronary artery disease
    Cheng, Judy W. M.
    CLINICAL THERAPEUTICS, 2006, 28 (12) : 1996 - 2007
  • [26] Ticagrelor in the management of coronary artery disease
    Loganath, Krithika
    Adamson, Philip D.
    Moss, Alastair J.
    FUTURE CARDIOLOGY, 2020, 17 (04) : 561 - 571
  • [27] Spontaneous Coronary Artery Dissection: Diagnosis and Management
    Yeo I.
    Feldman D.N.
    Kim L.K.
    Current Treatment Options in Cardiovascular Medicine, 2018, 20 (3)
  • [28] Coronary Artery Disease Management in Polyclinic
    Durusoy, Elcim
    Yildirim, Tarik
    Altun, Armagan
    TRAKYA UNIVERSITESI TIP FAKULTESI DERGISI, 2010, 27 : 13 - 18
  • [29] Adenosine echocardiography in the diagnosis of coronary artery disease
    Marwick, TH
    EUROPEAN HEART JOURNAL, 1997, 18 : D31 - D36
  • [30] Nanotechnology in diagnosis and treatment of coronary artery disease
    Karimi, Mahdi
    Zare, Hossein
    Nik, Amirala Bakhshian
    Yazdani, Narges
    Hamrang, Mohammad
    Mohamed, Elmira
    Zangabad, Parham Sahandi
    Basri, Seyed Masoud Moosavi
    Bakhtiari, Leila
    Hamblin, Michael R.
    NANOMEDICINE, 2016, 11 (05) : 513 - 530